Market Valuation: Actuate Therapeutics Inc. (ACTU)

Graphic logo of Actuate Therapeutics, Inc (ACTU)

The market trend for Actuate Therapeutics, Inc. (ACTU) shares, recorded at 0.01, is driven by a production outsourcing model that eliminates unnecessary infrastructure costs. Growth is supported by exclusive patents targeting resistance in brain and pancreatic tumors. Looking ahead, Actuate Therapeutics, Inc. (ACTU) plans the global rollout of elraglusib, leveraging Phase II test results to expand its presence in the oncology sector.

ACTU (actuatetherapeutics.com) Market Capitalization history from 08/14/2024 to 11/16/2026

Metric breakdowns and analytics for actuatetherapeutics.com (ACTU)

- current price and projected stock value:
- company stock exchange capitalization indicators:
Fundamental company valuation:Actuate Therapeutics Inc ACTU
Product sample of Actuate Therapeutics, Inc.

Market capitalization aggregates the value of all shares, reflecting the current investor consensus regarding the enterprise's total assets. This indicator measures institutional demand through the lens of market pricing. Analyzing the issuer's market value reveals that the valuation of Actuate Therapeutics, Inc. (ACTU) depends on the prospects of the GSK-3 inhibitor. Fluctuations in this metric signal a reassessment of the drug's clinical trial risks. The trend of this indicator determines the company's investment attractiveness within the biotechnology sector.

Competitors of Actuate Therapeutics, Inc. (ACTU)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value citiusonc.com (CTOR)|Market Value tuhurabio.com|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group